Related Experiment Video

Updated: Feb 1, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

9.3K

Insight into binding mechanisms of EGFR allosteric inhibitors using molecular dynamics simulations and free energy

Shanhe Wan1, Ruohong Yan1, Ying Jiang1

  • 1Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Science, Southern Medical University , Guangzhou , PR China.

Journal of Biomolecular Structure & Dynamics
|December 1, 2018
PubMed

Insights

New allosteric inhibitors, EAI001 and EAI045, offer a novel approach to combat drug-resistant lung cancer by targeting epidermal growth factor receptor (EGFR) differently. This research elucidates their unique mechanism, paving the way for next-generation cancer therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Drug Discovery

Background:

  • Lung cancer remains a leading cause of cancer mortality worldwide.
  • Epidermal growth factor receptor (EGFR) mutations drive non-small-cell lung cancer (NSCLC), with resistance developing to current therapies.
  • Existing EGFR inhibitors face challenges due to resistance mutations like T790M and C797S.

Purpose of the Study:

  • To elucidate the inhibitory mechanism of novel allosteric EGFR inhibitors, EAI001 and EAI045.
  • To provide a computational basis for the rational design of new EGFR allosteric inhibitors.
  • To explore alternative therapeutic strategies for EGFR-mutated NSCLC resistant to conventional treatments.

Main Methods:

  • Molecular dynamics simulations were employed to study EAI001 and EAI045 in complex with EGFR.
  • Free energy calculations were performed to analyze the binding interactions.
  • The study focused on the allosteric binding site, distinct from the ATP-binding pocket.

Main Results:

  • Detailed insights into the inhibitory mechanism of EAI001 and EAI045 as EGFR allosteric inhibitors were revealed.
  • The allosteric inhibitors bind to EGFR at a site independent of Cys 797, bypassing resistance mechanisms.
  • The findings highlight the potential of allosteric inhibition for overcoming drug resistance.

Conclusions:

  • EAI001 and EAI045 represent a promising new class of EGFR inhibitors for NSCLC treatment.
  • Understanding their allosteric mechanism is crucial for developing drugs that circumvent resistance.
  • This research lays the groundwork for designing effective allosteric inhibitors against challenging cancer mutations.
Keywords:
EAI001EAI045EGFRallosteric inhibitor

More Related Videos

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.3K
Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans08:12

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

3.4K

Related Concept Videos

Calculating Standard Free Energy Changes02:49

Calculating Standard Free Energy Changes

The free energy change for a reaction that occurs under the standard conditions of 1 bar pressure and at 298 K is called the standard free energy change. Since free energy is a state function, its value depends only on the conditions of the initial and final states of the system. A convenient and common approach to the calculation of free energy changes for physical and chemical reactions is by use of widely available compilations of standard state thermodynamic data. One method involves the...
24.9K
Nuclear Binding Energy02:13

Nuclear Binding Energy

The difference between the calculated and experimentally measured masses is known as the mass defect of the atom. In the case of helium-4, the mass defect indicates a “loss” in mass of 4.0331 amu – 4.0026 amu = 0.0305 amu. The loss in mass accompanying the formation of an atom from protons, neutrons, and electrons is due to the conversion of that mass into energy that is evolved as the atom forms. The nuclear binding energy is the energy produced when the atoms’ nucleons are bound...
14.8K
Cooperative Allosteric Transitions01:58

Cooperative Allosteric Transitions

Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
8.7K
Kinetic Molecular Theory: Molecular Velocities, Temperature, and Kinetic Energy03:07

Kinetic Molecular Theory: Molecular Velocities, Temperature, and Kinetic Energy

The kinetic molecular theory qualitatively explains the behaviors described by the various gas laws. The postulates of this theory may be applied in a more quantitative fashion to derive these individual laws.
29.9K
Molecular Kinetic Energy01:21

Molecular Kinetic Energy

The word "gas" comes from the Flemish word meaning "chaos," first used to describe vapors by the chemist J. B. van Helmont. Consider a container filled with gas, with a continuous and random motion of molecules. During collisions, the velocity component parallel to the wall is unchanged, and the component perpendicular to the wall reverses direction but does not change in magnitude. If the molecule’s velocity changes in the x-direction, then its momentum is changed.
5.7K
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.6K